These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32045933)

  • 1. Increased antioxidant response in medium-chain acyl-CoA dehydrogenase deficiency: does lipoic acid have a protective role?
    Nochi Z; Birkler RID; Fernandez-Guerra P; Hansen J; Wibrand F; Corydon TJ; Gregersen N; Olsen RKJ
    Pediatr Res; 2020 Oct; 88(4):556-564. PubMed ID: 32045933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the Mitochondrial Fatty Acid β-Oxidation Protein Medium-Chain Acyl-Coenzyme A Dehydrogenase Disrupts Oxidative Phosphorylation Protein Complex Stability and Function.
    Lim SC; Tajika M; Shimura M; Carey KT; Stroud DA; Murayama K; Ohtake A; McKenzie M
    Sci Rep; 2018 Jan; 8(1):153. PubMed ID: 29317722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability to oxidative stress in vitro in pathophysiology of mitochondrial short-chain acyl-CoA dehydrogenase deficiency: response to antioxidants.
    Zolkipli Z; Pedersen CB; Lamhonwah AM; Gregersen N; Tein I
    PLoS One; 2011 Apr; 6(4):e17534. PubMed ID: 21483766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental evidence for protein oxidative damage and altered antioxidant defense in patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Derks TG; Touw CM; Ribas GS; Biancini GB; Vanzin CS; Negretto G; Mescka CP; Reijngoud DJ; Smit GP; Wajner M; Vargas CR
    J Inherit Metab Dis; 2014 Sep; 37(5):783-9. PubMed ID: 24623196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disorders.
    van Eunen K; Volker-Touw CM; Gerding A; Bleeker A; Wolters JC; van Rijt WJ; Martines AM; Niezen-Koning KE; Heiner RM; Permentier H; Groen AK; Reijngoud DJ; Derks TG; Bakker BM
    BMC Biol; 2016 Dec; 14(1):107. PubMed ID: 27927213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?
    Olsen RK; Cornelius N; Gregersen N
    Mol Genet Metab; 2013; 110 Suppl():S31-9. PubMed ID: 24206932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
    Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
    Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide retrospective observational study of population newborn screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in the Netherlands.
    Jager EA; Kuijpers MM; Bosch AM; Mulder MF; Gozalbo ER; Visser G; de Vries M; Williams M; Waterham HR; van Spronsen FJ; Schielen PCJI; Derks TGJ
    J Inherit Metab Dis; 2019 Sep; 42(5):890-897. PubMed ID: 31012112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.
    Yusupov R; Finegold DN; Naylor EW; Sahai I; Waisbren S; Levy HL
    Mol Genet Metab; 2010 Sep; 101(1):33-9. PubMed ID: 20580581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCAD deficiency in Denmark.
    Andresen BS; Lund AM; Hougaard DM; Christensen E; Gahrn B; Christensen M; Bross P; Vested A; Simonsen H; Skogstrand K; Olpin S; Brandt NJ; Skovby F; Nørgaard-Pedersen B; Gregersen N
    Mol Genet Metab; 2012 Jun; 106(2):175-88. PubMed ID: 22542437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heptanoic and medium branched-chain fatty acids as anaplerotic treatment for medium chain acyl-CoA dehydrogenase deficiency.
    Karunanidhi A; Basu S; Zhao XJ; D'Annibale O; Van't Land C; Vockley J; Mohsen AW
    Mol Genet Metab; 2023 Nov; 140(3):107689. PubMed ID: 37660571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype and residual enzyme activity in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Are predictions possible?
    Tucci S; Wagner C; Grünert SC; Matysiak U; Weinhold N; Klein J; Porta F; Spada M; Bordugo A; Rodella G; Furlan F; Sajeva A; Menni F; Spiekerkoetter U
    J Inherit Metab Dis; 2021 Jul; 44(4):916-925. PubMed ID: 33580884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Anderson DR; Viau K; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2020 Jan; 129(1):13-19. PubMed ID: 31836396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with medium-chain acyl-coenzyme a dehydrogenase deficiency have impaired oxidation of fat during exercise but no effect of L-carnitine supplementation.
    Madsen KL; Preisler N; Orngreen MC; Andersen SP; Olesen JH; Lund AM; Vissing J
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1667-75. PubMed ID: 23426616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress induction by cis-4-decenoic acid: relevance for MCAD deficiency.
    Schuck PF; Ceolato PC; Ferreira GC; Tonin A; Leipnitz G; Dutra-Filho CS; Latini A; Wajner M
    Free Radic Res; 2007 Nov; 41(11):1261-72. PubMed ID: 17987455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygosity for a severe novel medium-chain acyl-CoA dehydrogenase (MCAD) mutation IVS3-1G > C that leads to introduction of a premature termination codon by complete missplicing of the MCAD mRNA and is associated with phenotypic diversity ranging from sudden neonatal death to asymptomatic status.
    Korman SH; Gutman A; Brooks R; Sinnathamby T; Gregersen N; Andresen BS
    Mol Genet Metab; 2004 Jun; 82(2):121-9. PubMed ID: 15171999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical characterization of variant medium-chain acyl-CoA dehydrogenase in fibroblasts from patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Coates PM; Indo Y; Young D; Hale DE; Tanaka K
    Pediatr Res; 1992 Jan; 31(1):34-8. PubMed ID: 1594327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic investigation of cultivated fibroblasts from patients with mitochondrial short-chain acyl-CoA dehydrogenase deficiency.
    Edhager AV; Stenbroen V; Nielsen NS; Bross P; Olsen RKJ; Gregersen N; Palmfeldt J
    Mol Genet Metab; 2014 Mar; 111(3):360-368. PubMed ID: 24485985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients.
    Odendaal C; Jager EA; Martines AMF; Vieira-Lara MA; Huijkman NCA; Kiyuna LA; Gerding A; Wolters JC; Heiner-Fokkema R; van Eunen K; Derks TGJ; Bakker BM
    BMC Biol; 2023 Sep; 21(1):184. PubMed ID: 37667308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First case report of medium-chain acyl-coenzyme A dehydrogenase deficiency in China.
    Liang C; Jiang M; Sheng H; Cai Y; Wu D; Yin X; Peng M; Liu L
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):681-4. PubMed ID: 25503862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.